Morgan Stanley’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $124K | Sell |
|
|||||
|
2025
Q1 | $296K | Buy |
|
|||||
|
2024
Q4 | $389K | Buy |
|
|||||
|
2024
Q3 | $714K | Buy |
|
|||||
|
2024
Q2 | $595K | Buy |
|
|||||
|
2024
Q1 | $586K | Sell |
|
|||||
|
2023
Q4 | $2.81M | Buy |
|
|||||
|
2023
Q3 | $261K | Sell |
|
|||||
|
2023
Q2 | $629K | Buy |
|
|||||
|
2023
Q1 | $482K | Buy |
|
|||||
|
2022
Q4 | $259K | Sell |
|
|||||
|
2022
Q3 | $405K | Sell |
|
|||||
|
2022
Q2 | $1.06M | Buy |
|
|||||
|
2022
Q1 | $390K | Buy |
|
|||||
|
2021
Q4 | $427K | Buy |
|
|||||
|
2021
Q3 | $479K | Sell |
|
|||||
|
2021
Q2 | $619K | Sell |
|
|||||
|
2021
Q1 | $4.14M | Sell |
|
|||||
|
2020
Q4 | $7.11M | Buy |
|
|||||
|
2020
Q3 | $2M | Sell |
|
|||||
|
2020
Q2 | $4.02M | Buy |
|
|||||
|
2020
Q1 | $312K | Sell |
|
|||||
|
2019
Q4 | $1.83M | Sell |
|
|||||
|
2019
Q3 | $1.43M | Buy |
|
|||||
|
2019
Q2 | $1.23M | Buy |
|
|||||
|
2019
Q1 | $421K | Sell |
|
|||||
|
2018
Q4 | $935K | Buy |
|
|||||
|
2018
Q3 | $950K | Sell |
|
|||||
|
2018
Q2 | $1.77M | Buy |
|
|||||
|
2018
Q1 | $912K | Sell |
|
|||||
|
2017
Q4 | $1.11M | Buy |
|
|||||
|
2017
Q3 | $1.28M | Buy |
|
|||||
|
2017
Q2 | $1.18M | Sell |
|
|||||
|
2017
Q1 | $2.5M | Buy |
|
|||||
|
2016
Q4 | $1.97M | Buy |
|
|||||
|
2016
Q3 | $2.18M | Buy |
|
|||||
|
2016
Q2 | $328K | Sell |
|
|||||
|
2016
Q1 | $573K | Buy |
|
|||||
|
2015
Q4 | $47K | Sell |
|
|||||
|
2015
Q3 | $182K | Sell |
|
|||||
|
2015
Q2 | $302K | Buy |
|
|||||
|
2015
Q1 | $218K | Sell |
|
|||||
|
2014
Q4 | $876K | Buy |
|
|||||
|
2014
Q3 | $210K | Sell |
|
|||||
|
2014
Q2 | $473K | Buy |
|
|||||
|
2014
Q1 | $262K | Sell |
|
|||||
|
2013
Q4 | $414K | Sell |
|
|||||
|
2013
Q3 | $776K | Sell |
|
|||||
|
2013
Q2 | $3.32M | Buy |
|